A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

Andrew McGarry; Lauren Seeberger; Sandra K. Kostyk; Peter Gibert; Kelvin L. Chou; Lynn A. Raymond; Joseph H. Friedman; Fredy J. Revilla; B.L. Scott; Juan Sanchez‐Ramos; Ira Shoulson; Karl Kieburtz; Kevin Biglan; Joel S. Perlmutter; Ramon L. Rodriguez; Amy Colcher; William Mallonee; Francis O. Walker; Nikolaus R. McFarland; Mary Jenkins; Rajeev Kumar; H. Diana Rosas; Stewart A. Factor; Michael McDermott; Richard Dubinsky; Vicki Wheelock; W. R. Wayne Martin; Joseph Jankovic; Valerie Suski; Padraig O’Suilleabhain; Christopher A. Ross; Karen E. Anderson; Oksana Suchowersky; Elisabeth A. de Blieck; Martha Nance; Eric S. Farbman; Elizabeth McCusker; Mark S. LeDoux; Carlos Singer; Kathleen M. Shannon; Donald S. Higgins; Andrew Feigin; Karen Marder; Russell L. Margolis; Joanne Wojcieszek; John N. Caviness; Mark Guttman; F Béal; Peter G. Como; Eric Molho

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

Andrew McGarry(Cooper Medical School of Rowan University), Lauren Seeberger(Georgetown University), Sandra K. Kostyk(Georgetown University), Peter Gibert, Kelvin L. Chou(Georgetown University), Lynn A. Raymond(Vancouver Coastal Health), Joseph H. Friedman(University of Washington), Fredy J. Revilla(University of Cincinnati), B.L. Scott(Georgetown University), Juan Sanchez‐Ramos(University of South Florida), Ira Shoulson(Baylor College of Medicine), Karl Kieburtz(Beth Israel Deaconess Medical Center), Kevin Biglan(Eli Lilly (United States)), Joel S. Perlmutter(University Radiology), Ramon L. Rodriguez(University of Florida), Amy Colcher(Georgetown University), William Mallonee(Georgetown University), Francis O. Walker(Wake Forest University), Nikolaus R. McFarland(Georgetown University), Mary Jenkins(Georgetown University), Rajeev Kumar(Georgetown University), H. Diana Rosas(Harvard University), Stewart A. Factor(Parkinson's and Movement Disorder Institute), Michael McDermott(Unknown), Richard Dubinsky(Georgetown University), Vicki Wheelock(Georgetown University), W. R. Wayne Martin(Georgetown University), Joseph Jankovic(Baylor College of Medicine), Valerie Suski(Georgetown University), Padraig O’Suilleabhain(Mayo Clinic), Christopher A. Ross(Johns Hopkins University), Karen E. Anderson, Oksana Suchowersky(Georgetown University), Elisabeth A. de Blieck(University of Rochester), Martha Nance(Hennepin County), Eric S. Farbman(Georgetown University), Elizabeth McCusker(Georgetown University), Mark S. LeDoux(University of Tennessee Health Science Center), Carlos Singer(University of Miami Health System), Kathleen M. Shannon(Georgetown University), Donald S. Higgins(Georgetown University), Andrew Feigin(Georgetown University), Karen Marder(Columbia University Irving Medical Center), Russell L. Margolis(Johns Hopkins University), Joanne Wojcieszek(Georgetown University), John N. Caviness(Mayo Clinic), Mark Guttman(Georgetown University), F Béal(Georgetown University), Peter G. Como(Georgetown University), Eric Molho(Georgetown University)

Unknown

January 1, 2017

Cited by 28

Related Papers

A polymorphic DNA marker genetically linked to Huntington's disease

|Nature|1983|2.3k

Genome-wide association study reveals genetic risk underlying Parkinson's disease

|Nature Genetics|2009|2k

The Parkinson Progression Marker Initiative (PPMI)

|Progress in Neurobiology|2011|1.9k

NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder

|Immunity|2004|1.7k

Huntington disease

|Nature Reviews Disease Primers|2015|1.6k